Population-based screening cohort study reveals no association between monoclonal gammopathy of undetermined significance (MGUS), smoldering multiple myeloma (SMM), multiple myeloma (MM), and alopecia

Arch Dermatol Res. 2024 Sep 14;316(9):627. doi: 10.1007/s00403-024-03372-8.
No abstract available

Keywords: Hair loss; Inflammatory hair loss; Multiple myeloma (MM), smoldering multiple myeloma (SMM), monoclonal gammopathy of undetermined significance (MGUS), alopecia; Nonscarring hair loss.

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Alopecia* / diagnosis
  • Alopecia* / epidemiology
  • Cohort Studies
  • Female
  • Humans
  • Male
  • Mass Screening / methods
  • Middle Aged
  • Monoclonal Gammopathy of Undetermined Significance* / complications
  • Monoclonal Gammopathy of Undetermined Significance* / diagnosis
  • Monoclonal Gammopathy of Undetermined Significance* / epidemiology
  • Multiple Myeloma* / complications
  • Multiple Myeloma* / diagnosis
  • Multiple Myeloma* / epidemiology
  • Smoldering Multiple Myeloma* / diagnosis
  • Smoldering Multiple Myeloma* / epidemiology